Dong‐Lim Kim

673 total citations
17 papers, 495 citations indexed

About

Dong‐Lim Kim is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Dong‐Lim Kim has authored 17 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Dong‐Lim Kim's work include Thyroid Cancer Diagnosis and Treatment (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Treatment and Management (4 papers). Dong‐Lim Kim is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Diabetes Treatment and Management (4 papers). Dong‐Lim Kim collaborates with scholars based in South Korea, Japan and United States. Dong‐Lim Kim's co-authors include Suk Kyeong Kim, Kee‐Ho Song, Tae Sook Hwang, Wan Seop Kim, Hye Seung Han, Won‐Jin Moon, Seo Young Oh, Young Bum Yoo, Nam Sun Paik and Nan Hee Kim and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Endocrinology and Thyroid.

In The Last Decade

Dong‐Lim Kim

15 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong‐Lim Kim South Korea 11 406 168 98 84 74 17 495
Shelby Holt United States 11 237 0.6× 213 1.3× 47 0.5× 60 0.7× 65 0.9× 20 398
A. Calvanese Italy 10 254 0.6× 111 0.7× 76 0.8× 59 0.7× 37 0.5× 23 392
Heidi A. Apsey United States 13 192 0.5× 100 0.6× 79 0.8× 122 1.5× 36 0.5× 23 388
Seo Young Oh South Korea 8 190 0.5× 73 0.4× 70 0.7× 55 0.7× 34 0.5× 25 420
Hojin Chang South Korea 12 249 0.6× 179 1.1× 51 0.5× 63 0.8× 26 0.4× 44 389
Anna de Fazio Australia 11 57 0.1× 94 0.6× 81 0.8× 58 0.7× 79 1.1× 22 359
Babak Movahedi United States 14 239 0.6× 496 3.0× 77 0.8× 19 0.2× 262 3.5× 30 634
Christina Narick United States 6 153 0.4× 60 0.4× 24 0.2× 25 0.3× 54 0.7× 8 322
Jana Makuc Slovenia 10 90 0.2× 93 0.6× 50 0.5× 31 0.4× 47 0.6× 25 271

Countries citing papers authored by Dong‐Lim Kim

Since Specialization
Citations

This map shows the geographic impact of Dong‐Lim Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Lim Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Lim Kim more than expected).

Fields of papers citing papers by Dong‐Lim Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Lim Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Lim Kim. The network helps show where Dong‐Lim Kim may publish in the future.

Co-authorship network of co-authors of Dong‐Lim Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Lim Kim. A scholar is included among the top collaborators of Dong‐Lim Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Lim Kim. Dong‐Lim Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Kim, Dong‐Lim, Seung‐Eun Lee, & Nan Hee Kim. (2023). Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease. Endocrinology and Metabolism. 38(1). 43–55. 24 indexed citations
3.
Kim, Suk Kyeong, et al.. (2018). Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea. The Korean Journal of Internal Medicine. 35(3). 641–651. 20 indexed citations
4.
An, Jee Hyun, Kee‐Ho Song, Dong‐Lim Kim, & Suk Kyeong Kim. (2016). Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer. Journal of International Medical Research. 45(1). 38–50. 10 indexed citations
5.
An, Jee Hyun, Kee‐Ho Song, Suk Kyeong Kim, et al.. (2014). RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma. Clinical Endocrinology. 82(5). 760–766. 35 indexed citations
6.
7.
Kim, Dong‐Lim. (2013). Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients. Diabetes & Metabolism Journal. 37(6). 429–429. 4 indexed citations
8.
Lee, Eunjung, et al.. (2011). The BRAFV600Emutation is associated with malignant ultrasonographic features in thyroid nodules. Clinical Endocrinology. 75(6). 844–850. 29 indexed citations
9.
Kim, Suk Kyeong, Tae Sook Hwang, Young Bum Yoo, et al.. (2011). Surgical Results of Thyroid Nodules according to a Management Guideline Based on the BRAFV600E Mutation Status. The Journal of Clinical Endocrinology & Metabolism. 96(3). 658–664. 113 indexed citations
10.
Kim, Dong‐Lim, et al.. (2011). Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes. Diabetes & Metabolism Journal. 35(2). 117–117. 5 indexed citations
11.
Kim, Dong‐Lim, et al.. (2010). Standards of Medical Care in Diabetes-2010 by American Diabetes Association: Dyslipidemia/Lipid treatment. 11(2). 100–100. 1 indexed citations
12.
13.
Kim, Dong‐Lim. (2009). Treating Tobacco Use and Dependence. 10(2). 92–92. 13 indexed citations
14.
Kim, Suk Kyeong, Dong‐Lim Kim, Hye Seung Han, et al.. (2008). Pyrosequencing Analysis for Detection of a BRAFV600E Mutation in an FNAB Specimen of Thyroid Nodules. Diagnostic Molecular Pathology. 17(2). 118–125. 130 indexed citations
15.
Phillips, Paul S, Theodore P. Ciaraldi, Dong‐Lim Kim, et al.. (2008). Myotoxic reactions to lipid-lowering therapy are associated with altered oxidation of fatty acids. Endocrine. 35(1). 38–46. 14 indexed citations
16.
Kim, Dong‐Lim, Kee‐Ho Song, & Suk Kyeong Kim. (2008). High Prevalence of Carcinoma in Ultrasonography-guided Fine Needle Aspiration Cytology of Thyroid Nodules. Endocrine Journal. 55(1). 135–142. 61 indexed citations
17.
Kim, Dong‐Lim, Kee‐Ho Song, Jung Hyun Lee, Kye Young Lee, & Suk Kyeong Kim. (2007). Rifampin-Induced Hypothyroidism without Underlying Thyroid Disease. Thyroid. 17(8). 793–795. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shelby Holt Breakdown of academic impact, for papers by A. Calvanese Breakdown of academic impact, for papers by Heidi A. Apsey Breakdown of academic impact, for papers by Seo Young Oh Breakdown of academic impact, for papers by Hojin Chang Breakdown of academic impact, for papers by Anna de Fazio Breakdown of academic impact, for papers by Babak Movahedi Breakdown of academic impact, for papers by Christina Narick Breakdown of academic impact, for papers by Jana Makuc
Rankless by CCL
2026